Gene-activated matrix harboring a miR20a-expressing plasmid promotes rat cranial bone augmentation.

atelocollagen bone augmentation gene-activated matrix in vivo gene transfer mir20a

Journal

Regenerative biomaterials
ISSN: 2056-3418
Titre abrégé: Regen Biomater
Pays: England
ID NLM: 101652150

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 07 09 2020
revised: 02 12 2020
accepted: 23 12 2020
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 20 3 2021
Statut: epublish

Résumé

Gene-activated matrix (GAM) has a potential usefulness in bone engineering as an alternate strategy for the lasting release of osteogenic proteins but efficient methods to generate non-viral GAM remain to be established. In this study, we investigated whether an atelocollagen-based GAM containing naked-plasmid (

Identifiants

DOI: 10.1093/rb/rbaa060 PMID: 33738113 PMC: PMC7955717
pubmed: 33738113
doi: 10.1093/rb/rbaa060
pii: rbaa060
pmc: PMC7955717
doi:

Types de publication

Journal Article

Langues

eng

Pagination

rbaa060

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

Rev Endocr Metab Disord. 2006 Jun;7(1-2):1-16
pubmed: 17051438
Biomed Mater Eng. 2013;23(3):163-72
pubmed: 23629530
J Clin Endocrinol Metab. 2012 Aug;97(8):E1515-23
pubmed: 22648654
Spine J. 2006 Jul-Aug;6(4):397-403; discussion 404
pubmed: 16825045
Rev Endocr Metab Disord. 2006 Jun;7(1-2):51-65
pubmed: 17029022
J Periodontol. 2004 Oct;75(10):1364-70
pubmed: 15562914
J Drug Target. 2017 Jan;25(1):49-57
pubmed: 27125178
J Biol Chem. 2009 Jun 5;284(23):15676-84
pubmed: 19342382
Biomaterials. 2013 Jul;34(21):5048-58
pubmed: 23578559
Circ Res. 2012 Feb 3;110(3):496-507
pubmed: 22302756
Angiogenesis. 2012 Dec;15(4):593-608
pubmed: 22696064
RNA Biol. 2011 Sep-Oct;8(5):829-38
pubmed: 21743293
J Vasc Surg. 2002 May;35(5):930-6
pubmed: 12021709
J Biol Chem. 2003 Jun 27;278(26):23270-7
pubmed: 12704187
Dev Dyn. 2007 Feb;236(2):502-11
pubmed: 17106887
Int J Nanomedicine. 2018 Nov 12;13:7395-7408
pubmed: 30519022
Gene Ther. 2002 Dec;9(24):1647-52
pubmed: 12457277
Yakugaku Zasshi. 2007 May;127(5):807-12
pubmed: 17473522
J Biol Chem. 2003 Sep 5;278(36):34181-8
pubmed: 12805376
Mol Med Rep. 2018 Jan;17(1):1667-1675
pubmed: 29138837
Eur J Pharm Biopharm. 2014 Aug;87(3):472-9
pubmed: 24813391
Ann Rheum Dis. 2013 Jun;72(6):1071-9
pubmed: 23087182
J Orthop Res. 2000 Mar;18(2):289-302
pubmed: 10815831
J Cell Biochem. 2011 Jul;112(7):1844-56
pubmed: 21416501
Nat Commun. 2016 Jan 14;7:10376
pubmed: 26765931
Nat Cell Biol. 2007 Jul;9(7):775-87
pubmed: 17589498
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5753-8
pubmed: 8650165
Annu Rev Biochem. 2005;74:711-38
pubmed: 15952901
Tissue Eng Part A. 2018 Apr;24(7-8):584-594
pubmed: 28726579
Biores Open Access. 2015 Feb 01;4(1):164-74
pubmed: 26309793
Biotechnol Adv. 2013 Dec;31(8):1695-706
pubmed: 23994567
J Bone Miner Res. 2005 Nov;20(11):2028-35
pubmed: 16234976
Arthritis Res Ther. 2008;10(3):110
pubmed: 18510784
J Bone Joint Surg Am. 2002 Jun;84(6):1032-44
pubmed: 12063342
Am J Vet Res. 2004 Sep;65(9):1223-32
pubmed: 15478769

Auteurs

Rena Shido (R)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Yoshinori Sumita (Y)

Basic & Translational Research Center for Hard Tissue Disease, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Masahito Hara (M)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Mayumi Iwatake (M)

Basic & Translational Research Center for Hard Tissue Disease, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Shun Narahara (S)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Mayumi Umebayashi (M)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Laboratory of Craniofacial Tissue Engineering and Stem Cells, Faculty of Dentistry, McGill University, 3640 University Street, M43, Montreal, Quebec H3A 2B2, Canada.

Kei-Ichiro Miura (KI)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Yukinobu Kodama (Y)

Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Izumi Asahina (I)

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Classifications MeSH